Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
[A blue and white logo Description automatically generated] Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK VANCOUVER, BC, 13 October 2023 – Mydecine Innovations Group, Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, announces that it has completed its admission to the Access